Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VBIV

VBI Vaccines

$1.90

(0.00%)

08:08
09/25/18
09/25
08:08
09/25/18
08:08
Hot Stocks
VBI Vaccines initiates enrollment in high-dose arm of VBI-1901 study »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$1.80

-0.08 (-4.26%)

08:02
09/16/18
09/16
08:02
09/16/18
08:02
Hot Stocks
VBI calls Globes article 'false' and 'gross mischaracterization' of facts »

VBI Vaccines issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
VBIV

VBI Vaccines

$1.98

0.15 (8.20%)

, NVIV

InVivo Therapeutics

$1.98

0.02 (1.02%)

08:08
08/15/18
08/15
08:08
08/15/18
08:08
Hot Stocks
VBI Vaccines announces Christopher McNulty as CFO »

VBI Vaccines (VBV)…

VBIV

VBI Vaccines

$1.98

0.15 (8.20%)

NVIV

InVivo Therapeutics

$1.98

0.02 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$2.73

-0.16 (-5.54%)

05:55
07/19/18
07/19
05:55
07/19/18
05:55
Conference/Events
VBI Vaccines management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

VBIV

VBI Vaccines

$2.89

(0.00%)

04:55
07/18/18
07/18
04:55
07/18/18
04:55
Conference/Events
VBI Vaccines management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

Over a quarter ago
VBIV

VBI Vaccines

$2.92

0.01 (0.34%)

07:19
07/16/18
07/16
07:19
07/16/18
07:19
Conference/Events
VBI Vaccines management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

VBIV

VBI Vaccines

$3.17

0.23 (7.82%)

11:06
05/10/18
05/10
11:06
05/10/18
11:06
Recommendations
VBI Vaccines analyst commentary at BMO Capital »

VBI Vaccines price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

VBIV

VBI Vaccines

$2.94

0.08 (2.80%)

08:21
05/10/18
05/10
08:21
05/10/18
08:21
Conference/Events
VBI Vaccines to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$2.94

0.08 (2.80%)

07:34
05/10/18
05/10
07:34
05/10/18
07:34
Hot Stocks
VBI Vaccines announces 'positive' final Phase 1 study results for VBI-1501 »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$3.45

0.19 (5.83%)

08:09
04/19/18
04/19
08:09
04/19/18
08:09
Hot Stocks
VBI Vaccines completes enrollment in PROTECT Phase 3 clinical study »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.